EDPR inks 63MW Spanish wind, solar supply bargain

• Developer claims it has actually secured 86% of the 7GW targeted global renewables capability build-out for 2019-2022

EDP Renewables (EDPR) has actually signed a 15-year power purchase contract (PPA) with pharmaceutical company Novartis to offer electrical energy from a 63MW portfolio of renewable resource projects in Spain.

The portfolio consists of a 36MW wind farm and a 26.8 MW solar center expected to be mounted in 2022-2023.

With this newest contract EDPR has actually currently protected PPAs for projects amounting to 229MW to be installed from 2020 to 2023.

Since today, EDPR said it has safeguarded 86% of the 7GW targeted worldwide wind as well as solar capability build-out for the 2019-2022 period, as interacted in the business's calculated update on March 2019.

EDPR will certainly remain to analyse as well as develop projects that fulfill its interior danger and also profitability criteria.

EDPR acting CEO Rui Teixeira mentioned: "The announcement of this new PPA demonstrates that we keep a rapid development in the direction of the execution of our business strategy however mainly the significance of renewables as a competitive and also tidy source of power for our customers across different sectors".

Novartis primary sustainability police officer Montse Montaner added: "At Novartis, ecological sustainability is lined up with our objective to reimagine medicine to enhance and also prolong people's lives.

" Energy efficiency and also renewable resource solutions are the keystones of our technique for decreasing discharges. We are proud to be signed up with by EDP Renewables as well as various other like-minded partners on our environmental sustainability journey."